The Association of International Pharmaceutical Manufacturers (AIPM) pays special attention to the regulatory issues. During the years of AIPM activity hundreds of comments and suggestions to the laws and by-law acts were prepared, numerous meetings with the main regulators of the industry such as Ministry of Healthcare and Social Development, Federal Service on Surveillance in the Sphere of Healthcare and Social Development, Federal Antimonopoly Service and others were held.
Currently, due to the changes in the legislation, especially coming into effect of the new Federal Law “On Drug Circulation” of April 12, 2010 #61-FZ starting from September 1, 2010 we face a number of difficulties with the enforcement and we plan to inform you about the situation on this web page.
The AIPM Regulatory Committee
Version for printing